Amalia Azzariti
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 12
- Drug Transport and Resistance Mechanisms 11
- HER2/EGFR in Cancer Research 10
- Pancreatic and Hepatic Oncology Research 9
- Cancer Research top 5%
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms 16
- Melanoma and MAPK Pathways 14
- Hepatology top 5%
- Biomaterials top 5%
-
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Letizia PorcelliAngelo ParadisoNicola SilvestrisRosa Maria IacobazziR. FonteGianluigi GiannelliAntonia BellizziGabriella Guida
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)ACS Nano (1 paper)
- Partner nations
- ItalyUnited StatesChina
In The Last Decade
Amalia Azzariti
130 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 131
- Oncology 1.4k
- Cancer Research 601
- Molecular Biology 1.9k
- Hepatology 180
- Biomaterials 210
Countries citing papers authored by Amalia Azzariti
This map shows the geographic impact of Amalia Azzariti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amalia Azzariti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amalia Azzariti more than expected).
Fields of papers citing papers by Amalia Azzariti
This network shows the impact of papers produced by Amalia Azzariti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amalia Azzariti. The network helps show where Amalia Azzariti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amalia Azzariti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 6 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 41 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 10 | |
| 14 | 2017 | 52 | |
| 15 | 2016 | 17 | |
| 16 | 2014 | 3 | |
| 17 | 2014 | 8 | |
| 18 | 2013 | 50 | |
| 19 | 2010 | 9 | |
| 20 | 2007 | 111 |
About Amalia Azzariti
Amalia Azzariti is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 132 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (16 papers), Melanoma and MAPK Pathways (14 papers), Colorectal Cancer Treatments and Studies (13 papers), Lung Cancer Treatments and Mutations (12 papers), Cancer Treatment and Pharmacology (12 papers), Drug Transport and Resistance Mechanisms (11 papers), HER2/EGFR in Cancer Research (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (601 citations) and Molecular Biology (1.9k citations). Amalia Azzariti has collaborated with scholars based in Italy, United States and China. Frequent co-authors include Letizia Porcelli, Angelo Paradiso, Nicola Silvestris, Rosa Maria Iacobazzi, R. Fonte, Gianluigi Giannelli, Antonia Bellizzi, Gabriella Guida, Michele Guida and Stephan J. Reshkin. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.